National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 312 cases where Vaccine is HPV4 and Symptom is Death

Case Details

This is page 15 out of 32

Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next


VAERS ID: 782839 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-10-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131810USA012438

Write-up: This initial spontaneous report was received on 25-OCT-2018 from a physician via a company field representative and refers to a 12 year old patient of unknown gender. The patient had no pertinent medical history or drug reactions/allergies and was taking no concomitant medications. On an unspecified date, the patient received GARDASIL intramuscularly for the indication of human papilloma virus (HPV) vaccination (dose and lot # not provided). It was unspecified how many doses in the series the patient received. An unspecified period of time after receiving GARDASIL, the patient died. Cause of death was not specified. There were no lab diagnostics/studies performed. The physician did not provide causality assessment. The physician told the field representative that Merck was sued. Upon internal review, death was considered medically significant. Additional information has been requested.; Reported Cause(s) of Death: Cause of Death: Unknown by reporter.


VAERS ID: 789407 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-12-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 3 UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Amyotrophic lateral sclerosis, Autopsy, Central nervous system inflammation, Death, Gait disturbance, Grip strength decreased, Life support, Muscle atrophy, Muscular weakness, Paraesthesia, Paralysis, Quadriplegia, Spinal cord disorder
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Parkinson-like events (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Respiratory failure (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2009-03-01
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131811USA012613

Write-up: This spontaneous report was received from a physician via an online article and refers to a 14-year-old female patient. The patient''s medical history, concurrent conditions and concomitant medications were not reported. On an unknown date in 2008, the patient was vaccinated with a third dose of GARDASIL (route of administration, lot# and expiration date were not provided) for prophylaxis. On an unknown date in 2008 (also reported as nearly two years before 20-MAR-2009), reported as just months after her third and final booster GARDASIL shot, the patient developed degenerative muscle disease. She tripped on a hurdle than others in her class cleared easily. Moreover, the disease rapidly progressed; both her legs and then her arms became weak. She began to limp and had trouble gripping objects. The patient also felt pins and needles in her feet and her muscles athropied. The reporter stated that the disease progressed very rapidly, more quickly than typical for young ALS patients. Within a year, the patient was paralyzed (also reported as nearly completely paralyzed), a quadriplegic and was breathing only with the help of life support, but throughout the course of her illness her mind was as sharp as ever. Shortly afterwards, the patient died on an unknown date in March 2009, at the age of 15 years old. The cause of death was reported as amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig''s disease. The autopsy was performed on an unknown day. The autopsy results showed that the patient''s spinal cord was so inflammatory, very different that normally seen in ALS (as reported). The reporter considered amyotrophic lateral sclerosis to be related to GARDASIL. The physician reported that both the timing of the symptoms and autopsy results "suggest a link between" the vaccine and the fatal cases of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig''s disease. She also stated that with only two confirmed cases, they did not know for sure if it was coincidence or if they were connected to the vaccine. The pathology features all supported a temporal association between the illness and vaccination. The relatedness between the spinal cord inflammatory and GARDASIL was not provided. Upon internal review, the amyotrophic lateral sclerosis and spinal cord disorder were considered to be medically significant. Additionally, the event of amyotrophic lateral sclerosis was considered as caused disability. This is one of the several reports from the same reporter. Sender''s Comments: US-009507513-1812USA000379: US-009507513-1812USA000380: Reported Cause(s) of Death: amyotrophic lateral sclerosis; Autopsy-determined Cause(s) of Death: Spinal cord was so inflammatory. That is very different from what we normally see in ALS.


VAERS ID: 789408 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-12-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Amyotrophic lateral sclerosis, Autopsy, Death, Disease progression, Spinal cord disorder
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2008-08-01
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131812USA000379

Write-up: This spontaneous report was received from a physician via an online article and refers to a 20-year-old female patient. The patient''s medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a first dose of GARDASIL (route of administration, lot# and expiration date were not provided) for prophylaxis. On an unknown date, reported as within four months after her first GARDASIL shot, the patient developed symptoms of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig''s disease. The reporter stated that disease progressed very fast(the disease progressed more quickly than typical for young ALS patients). She died on an unknown date in August 2008 (reported as last August), reported as 28 months later (also reported as 13 months later), at the age of 22 years old. The cause of death was reported as amyotrophic lateral sclerosis (ALS). An autopsy was performed. The autopsy results showed that the patient''s spinal cord was so inflammatory(also reported as distinct immunological features), very different that normally seen in ALS (as reported). The reporter considered amyotrophic lateral sclerosis to be related to GARDASIL. The physician reported that both the timing of the symptoms and autopsy results "suggest a link between" the vaccine and the fatal cases of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig''s disease. She also stated that with only two confirmed cases, they did not know for sure if it was coincidence or if they were connected to the vaccine. The pathology features all supported a temporal association between the illness and vaccination. The relatedness between the spinal cord inflammatory and GARDASIL was not provided. Upon internal review, the amyotrophic lateral sclerosis and spinal cord inflammatory (disorder) were considered to be medically significant. This is one of the several reports from the same reporter. Sender''s Comments: US-009507513-1812USA000380: US-009507513-1811USA012613: Reported Cause(s) of Death: amyotrophic lateral sclerosis; Autopsy-determined Cause(s) of Death: spinal cord was so inflammatory. That is very different from what we normally see in ALS.


VAERS ID: 790906 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-12-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Injury, Neoplasm progression
SMQs:, Malignancy related conditions (narrow), Accidents and injuries (narrow), Hostility/aggression (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131812USA003673

Write-up: This spontaneous report was received from a non-healthcare professional via social media concerning a female patient of unknown age. The patient''s medical history, historical drugs, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with GARDASIL (dose, unit, route, lot # and expiration unknown) for prophylaxis. On an unknown date, the patient had tumor growth and serious injuries. On an unknown date, the patient died (cause of death was not reported). It was unknown if autopsy performed. The outcome of the events neoplasm progression and injury was unknown. The reporter did not provide the causality assessment for the events. The reporter considered the event injury to be medically significant. Reported Cause(s) of Death: Unknown cause of death.


VAERS ID: 790907 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-12-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Epilepsy, Seizure
SMQs:, Systemic lupus erythematosus (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131812USA003708

Write-up: This spontaneous report as received from a non-healthcare professional via social media regarding a 14-year old female patient. The patient''s medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with GARDASIL (lot, expiry date, dose, strength were not reported) for prophylaxis. On an unknown date, the patient experienced seizure and epilepsy. On an unknown date, the patient died due to unknown cause (medically significant). It was unknown if autopsy was performed. Outcome of seizure and epilepsy was unknown. Causality for the events was not reported. Upon internal review, the events seizure and epilepsy were determined to be medically significant. This is one of the three reports from the same reporter. Reported Cause(s) of Death: unknown cause of death.


VAERS ID: 791324 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2018-12-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Amenorrhoea, Balance disorder, Death, Fatigue, Mobility decreased
SMQs:, Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Vestibular disorders (broad), Fertility disorders (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131812USA003828

Write-up: This spontaneous report was received from an other reporter, who posted an information on independent site in social media and refers to a female (also reported as gender unknown) patient of unknown age. The patient''s medical history, concurrent conditions and concomitant drugs were not reported. On an unknown date, the patient was vaccinated with GARDASIL (dose, lot#, expiry date, route and site of administration were not reported) for prophylaxis. Other suspect therapies included VIOXX tablets (dose, frequency, lot#, expiry date and indication were not reported). On an unknown dates, the patient experienced difficulty to get out of bed, fatigue (sometimes enormous fatigue), problems with balance and an unspecified other symptoms. She also, on an unknown date, lost her period. On an unknown date, the patient died (also reported as "killed"). Cause of death and information about autopsy were not reported. Action taken with suspected therapies was not reported. The outcome of non-fatal events was unknown. The relatedness between the event and suspected drugs was not reported.


VAERS ID: 799758 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2019-02-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Autoimmune disorder, Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131902USA000328

Write-up: This initial spontaneous report was received from an on-line article that was posted on social media and concerns an unspecified amount of patients who were vaccinated with GARDASIL. The article mentioned that the GARDASIL vaccine causes autoimmune problems that cause sudden debilitation and/or death. It was also noted that to date, it was believed that GARDASIL was responsible for the death of 121 young women (cause not specified) and for 57,520 reports of adverse events obtained by the Vaccine Adverse Events Reporting System (VAERS). All of the events were considered related to GARDASIL. Upon internal review, autoimmune problems and death of 121 young women were considered to be medically significant. Autoimmune problems were considered disabling. This is one of several reports received from the same reporter.; Sender''s Comments: US-009507513-0807USA02497:; Reported Cause(s) of Death: death; autoimmune disorder.


VAERS ID: 800981 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2019-02-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131902USA002816

Write-up: This spontaneous report was received from a consumer via Pfizer refers to her daughter of unknown age. The patient concurrent condition, concomitant medication and medical history were unknown. On an unknown date, the patient was vaccinated with GARDASIL (strength, dose, frequency, route of administration, lot # and expiry date unspecified) for prophylaxis. On an unknown date, the patient died (death). The consumer also reported about 354 deaths due to GARDASIL. The consumer reported that her daughter''s information was on goggle. It was unable to clarify if reporter was referring to her daughter as one of the 354 deaths. The cause of death was not reported. It was unknown if autopsy was done. Causality assessment was also not reported.; Reported Cause(s) of Death: unknown.


VAERS ID: 806343 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2019-03-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Arrhythmia, Death
SMQs:, Cardiomyopathy (broad), Cardiac arrhythmia terms, nonspecific (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131903USA007463

Write-up: This spontaneous report was received from a pharmacist via company representative concerning to a 21-year-old female patient. The patient''s concurrent conditions, medical history, drug reaction or allergies and concomitant medications were not reported. On an unspecified day in 2007 (reported as 12 years ago), the patient received a dose of GARDASIL (dose number, route of administration, lot# and expiration date were not reported). The pharmacist stated that he heard about a court case where the female patient died from arrhythmia after the administration of GARDASIL. It was unknown if an autopsy was performed. No additional information was provided. The causal relationship between de patient''s death and GARDASIL was unknown.; Reported Cause(s) of Death: developed a heart arrhythmia that caused death.


VAERS ID: 809522 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2019-04-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 3 UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131904USA005236

Write-up: This initial spontaneous report was received from a licensed practical nurse (LPN) via a Company representative and refers to a 21 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. The patient died in 2008 after receiving her third dose of GARDASIL (lot # not provided) (also reported that the patient died an unspecified time after receiving the third dose in 2008). Dates of the three doses were not provided. Cause of death was not specified. The LPN said that patients at the office were asking questions about the event/incident because there have been multiple online posts being made about the event (also reported as reports of the death are being circulated on the internet). The Company employee stated that the "lawsuit just got settled" so that is why people were asking about it again. The LPN asked the Company employee what the Company had to say about the incident. Causality was not specified. Upon internal review, death was considered to be medically significant. The LPN did not want to be contacted for follow-up.; Reported Cause(s) of Death: died.


Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=15&SYMPTOMS[]=Death_%2810011906%29&VAX[]=HPV4


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166